好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Stroke Prevention in 2004

Friday 04/30/04
01:15 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Mitchell S. Elkind, MD, MS, FAAN
Cerebrovascular Disease and Interventional Neurology
Upon completion:
Participants should be able to discuss the evidence linking inflammatory markers, sleep apnea, and the metabolic syndrome and carotid stenosis to risk of stroke; recognize when to look for and how to diagnose these conditions in patients with stroke; use markers of inflammation and measures of insulin resistance appropriately in the evaluation of stroke patients; refer patients appropriately for sleep studies; treat patients directly or refer them for appropriate treatment by others; decide when patients should undergo cerebral revascularization; and rationally choose between carotid endarterectomy or carotid angioplasty and stenting.
No CME available
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
01:15 PM - 01:25 PM Introduction: A New Paradigm for Stroke Prevention
Mitchell S. Elkind, MD, MS, FAAN
01:25 PM - 02:00 PM Inflammation as a Stroke Risk Factor: The Role of CRP and Other Measures
Mitchell S. Elkind, MD, MS, FAAN
02:00 PM - 02:45 PM Sleep Apnea, Hypertension and Stroke
Antonio Culebras, MD, FAHA, FAAN
02:45 PM - 03:00 PM Break
03:00 PM - 03:45 PM The Metabolic Syndrome and Insulin Resistance in Stroke Prevention
Brett M. Kissela, MD, MS, FAAN
03:45 PM - 04:30 PM Carotid Endarterectomy and Stenting: Just the Facts
Helmi L. Lutsep, MD, FAAN
04:30 PM - 05:00 PM Questions and Answers
Faculty Disclosures
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
No disclosure on file
Antonio Culebras, MD, FAHA, FAAN Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received publishing royalties from a publication relating to health care. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a RESEARCH REVIEWER with DEPARTMENT OF DEFENSE. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a REVIEWER with DOD.
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS.
Helmi L. Lutsep, MD, FAAN Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.